Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Reduced Immune-Cell Infiltration in MHC Class I Negative DLBCL

Kanutte Huse, Yngvild Blaker, Jillian Frances Wise, Ankush Sharma, Leo Meriranta, Kathrine Thuestad Isaksen, Ivana Spasevska, Sigve Nakken, Vera Hilden, Mette Førsund, Sirpa Leppä, Erlend B. Smeland, Harald Holte, June Helen Myklebust

Blood (2023) 142 (Supplement 1): 179.

https://doi.org/10.1182/blood-2023-189098

Published: 2023

Journal Articles

Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma

Blood (2022) 140 (Supplement 1): 6411–6412.

https://doi.org/10.1182/blood-2022-169856

Published: 2022

Journal Articles

Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma

Blood (2021) 138 (Supplement 1): 3519.

https://doi.org/10.1182/blood-2021-152801

Published: 2021

Journal Articles

Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma

Morten P Oksvold, PhD MSC, Ulrika Warpman Berglund, PhD, Helge Gad, PhD, Baoyan Bai, PhD, Trond Stokke, PhD, Idun D Rein, Msc, Therese Pham, Kumar Sanjiv, PhD, Geir Frode Øy, PhD, Jens Henrik Norum, PhD, Erlend B. Smeland, PhD MD, June Helen Myklebust, PhD, Thomas Helleday, PhD, Thea Kristin Våtsveen, PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-140943

Published: 2020

Journal Articles

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Ivana Spasevska, Sarah Josefsson, PhD MSc, Yngvild Nuvin Blaker, MD PhD, Chloe B. Steen, PhD, Ankush Sharma, PhD, Kushi Kushekhar, PhD MSc, Saskia Meyer, PhD, Arne Kolstad, MD PhD, Klaus Beiske, MD PhD, Harald Holte, MD PhD, Bjørn Østenstad, MD PhD, Eva Kimby, MD PhD, Johanna Olweus, PhD, Kjetil Tasken, PhD, Suzanne Lorenz, PhD, Erlend B. Smeland, PhD MD, Ash A. Alizadeh, MD PhD, Kanutte Huse, PhD, June Helen Myklebust, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-142380

Published: 2020

Journal Articles

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Baoyan Bai, PhD, Daniel Vodák, BS, Sigve Nakken, PhD, Jillian F. Wise, PhD, Yngvild Nuvin Blaker, MD PhD, Ole Christian Lingjærde, PhD, Marianne Brodtkorb, MD PhD, Vera Hilden, Gunhild Trøen, Suzanne Lorenz, PhD, Michael S. Lawrence, PhD, Ola Myklebost, PhD, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Eivind Hovig, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD, June Helen Myklebust, PhD

Blood (2019) 134 (Supplement_1): 20.

https://doi.org/10.1182/blood-2019-128403

Published: 2019

Journal Articles

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Blood (2019) 134 (Supplement_1): 1497.

https://doi.org/10.1182/blood-2019-131072

Published: 2019

Journal Articles

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Kathrine T. Isaksen, MD, Klaus Beiske, MD PhD, Erlend B. Smeland, MD PhD, Judit Jørgensen, MD PhD, Marianne Brodtkorb, MD PhD, June Helen Myklebust, PhD, Mats Jerkeman, MD Professor, Leo Meriranta, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sirpa Leppa, MD PhD, David W. Scott, MBChB, PhD, Harald Holte, MD PhD, Yngvild Nuvin Blaker, MD PhD

Blood (2019) 134 (Supplement_1): 1485.

https://doi.org/10.1182/blood-2019-121467

Published: 2019

Journal Articles

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Blood (2014) 123 (8): 1214–1217.

https://doi.org/10.1182/blood-2013-11-536433

Published: 2014

Includes: Supplemental data

Journal Articles

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

Marianne Brodtkorb, Ole Christian Lingjærde, Kanutte Huse, Gunhild Trøen, Marit Hystad, Vera I. Hilden, June H. Myklebust, Ellen Leich, Andreas Rosenwald, Jan Delabie, Harald Holte, Erlend B. Smeland

Blood (2014) 123 (7): 1051–1054.

https://doi.org/10.1182/blood-2013-07-512392

Published: 2014

Includes: Supplemental data

Journal Articles

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Blood (2013) 122 (21): 73.

https://doi.org/10.1182/blood.V122.21.73.73

Published: 2013

Journal Articles

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Blood (2013) 122 (18): 3165–3168.

https://doi.org/10.1182/blood-2013-04-496893

Published: 2013

Includes: Supplemental data

Journal Articles

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Blood (2012) 120 (21): 545.

https://doi.org/10.1182/blood.V120.21.545.545

Published: 2012

Journal Articles

Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab

Björn Engelbrekt Wahlin, MD, PhD, Christer Sundström, Harald Holte, Birgitta Sander, MD, Ph.D., Bjørn Østenstad, Peter de Nully Brown, Erlend B. Smeland, Jan Delabie, Birger Christensson, M.D., Ph.D., Eva Kimby, M.D., Ph.D.

Blood (2011) 118 (21): 1641.

https://doi.org/10.1182/blood.V118.21.1641.1641

Published: 2011

Journal Articles

Bone Morphogenetic Proteins Inhibit CD40L- and IL-21-Induced Ig Production In Human B Cells: Differential Effects of BMP-6 and BMP-7

Kanutte Huse, Maren Bakkeb∅, Lise Forfang, Vera I. Hilden, Erlend B. Smeland, June H. Myklebust

Blood (2010) 116 (21): 1745.

https://doi.org/10.1182/blood.V116.21.1745.1745

Published: 2010

Journal Articles

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Blood (2008) 112 (11): 475.

https://doi.org/10.1182/blood.V112.11.475.475

Published: 2008

Journal Articles

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

Blood (2008) 112 (8): 3126–3129.

https://doi.org/10.1182/blood-2008-05-154013

Published: 2008

Includes: Supplemental data

Journal Articles

Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.

Georg Lenz, MD, George W. Wright, PhD, Sandeep Dave, MD, Wenming Xiao, PhD, John Powell, MS, Andreas Rosenwald, MD, Hans-Konrad Muller-Hermelink, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Jan Delabie, MD, Erlend B. Smeland, MD, Lisa Rimsza, MD, Richard I. Fisher, MD, Wing C. Chan, MD, Louis M. Staudt, MD

Blood (2007) 110 (11): 2631.

https://doi.org/10.1182/blood.V110.11.2631.2631

Published: 2007

Journal Articles

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Kanutte Huse, M.S, Maren Bakkebo, M.S, Morten Oksvold, PhD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD

Blood (2007) 110 (11): 2605.

https://doi.org/10.1182/blood.V110.11.2605.2605

Published: 2007

Journal Articles

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Georg Lenz, MD, George Wright, PhD, Sandeep Dave, MD, Alexander Kohlmann, PhD, Wenming Xiao, PhD, John Powell, MS, Hong Zhao, Weihong Xu, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Lorraine May, MD, Dennis D. Weisenburger, MD, Tim Greiner, MD, Julie Vose, MD, James O. Armitage, MD, Javeed Iqbal, MD, Martin Bast, MD, Kai Fu, MD, Elias Campo, MD, Emili Montserrat, MD, Armando Lopez-Guillermo, MD, Pedro Jares, MD, Antonio Martinez, MD, Betty Gibbs, MD, Lisa M. Rimsza, MD, Richard I. Fisher, MD, Rita M. Braziel, MD, Ray Tubbs, MD, James Cook, MD, Brad Pohlman, MD, John Sweetenham, MD, Gunhild Troen, MD, Erlend B. Smeland, MD, Jan Delabie, MD, Stein Kvaloy, MD, Harald Holte, MD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, Nicole Grant, MD, Elena Hartmann, MD, Andreas Rosenwald, MD, German Ott, MD, Hans-Konrad Muller-Hermelink, MD, T. Andrew Lister, MD, Mickey Williams, PhD, Lothar Wieczorek, PhD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2007) 110 (11): 348.

https://doi.org/10.1182/blood.V110.11.348.348

Published: 2007

NARROW

Reduced Immune-Cell Infiltration in MHC Class I Negative DLBCL

Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma

Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma

Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

EZH2 mutations are frequent and represent an early event in follicular lymphoma

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab

Bone Morphogenetic Proteins Inhibit CD40L- and IL-21-Induced Ig Production In Human B Cells: Differential Effects of BMP-6 and BMP-7

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only